nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Ambrisentan use for pulmonary arterial hypertension in a post-authorization drug registry: The VOLibris Tracking Study
|
Vachiéry, Jean-Luc |
|
2017 |
36 |
4 |
p. 399-406 8 p. |
artikel |
2 |
An ACE in the hole: Unraveling gastrointestinal bleeding in left ventricular assist systemsAn ACE In The Hole: Unraveling Gastrointestinal Bleeding in Left Ventricular Assist Systemsretain-->
|
Schurr, James W. |
|
2017 |
36 |
4 |
p. 373-375 3 p. |
artikel |
3 |
Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices
|
Houston, Brian A. |
|
2017 |
36 |
4 |
p. 380-385 6 p. |
artikel |
4 |
Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management—An analysis of the International Society for Heart and Lung Transplantation Registry
|
Wever-Pinzon, Omar |
|
2017 |
36 |
4 |
p. 407-417 11 p. |
artikel |
5 |
Clinical outcomes associated with INTERMACS-defined right heart failure after left ventricular assist device implantation
|
LaRue, Shane J. |
|
2017 |
36 |
4 |
p. 475-477 3 p. |
artikel |
6 |
Editorial Board
|
|
|
2017 |
36 |
4 |
p. A4- 1 p. |
artikel |
7 |
Effect of β2-adrenergic receptor stimulation on lung fluid in stable heart failure patients
|
Taylor, Bryan J. |
|
2017 |
36 |
4 |
p. 418-426 9 p. |
artikel |
8 |
Exchange of a HeartWare HVAD to a HeartMate 3 left ventricular assist device
|
Hanke, Jasmin S. |
|
2017 |
36 |
4 |
p. 480-481 2 p. |
artikel |
9 |
Health care utilization and consequences of readmission in the first year after lung transplantation
|
Mollberg, Nathan M. |
|
2017 |
36 |
4 |
p. 443-450 8 p. |
artikel |
10 |
Impact of age on incidence and prevalence of moderate-to-severe cellular rejection detected by routine surveillance biopsy in pediatric heart transplantation
|
Zinn, Matthew D. |
|
2017 |
36 |
4 |
p. 451-456 6 p. |
artikel |
11 |
Information for Readers
|
|
|
2017 |
36 |
4 |
p. A5- 1 p. |
artikel |
12 |
Kidney transplantation as a therapeutic option for end-stage renal disease long after heart transplantation: Should we all do it?
|
Perrault, Louis P. |
|
2017 |
36 |
4 |
p. 378-379 2 p. |
artikel |
13 |
Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome
|
Hascoët, Sébastien |
|
2017 |
36 |
4 |
p. 386-398 13 p. |
artikel |
14 |
Optimal ex vivo lung perfusion techniques with oxygenated perfusate
|
Noda, Kentaro |
|
2017 |
36 |
4 |
p. 466-474 9 p. |
artikel |
15 |
Screening for chromosomally integrated human herpesvirus 6 status in solid-organ donors and recipients
|
Das, Bibhuti B. |
|
2017 |
36 |
4 |
p. 481- 1 p. |
artikel |
16 |
Systolic and diastolic unloading by mechanical support of the acute vs the chronic pressure overloaded right ventricle
|
Verbelen, Tom |
|
2017 |
36 |
4 |
p. 457-465 9 p. |
artikel |
17 |
Table of Contents
|
|
|
2017 |
36 |
4 |
p. A6-A8 nvt p. |
artikel |
18 |
Treatment of pulmonary arterial hypertension in Eisenmenger syndrome: Practice makes (almost) perfect
|
Vachiery, Jean-Luc |
|
2017 |
36 |
4 |
p. 376-377 2 p. |
artikel |
19 |
Use of sirolimus in pediatric heart transplant patients: A multi-institutional study from the Pediatric Heart Transplant Study Group
|
Rossano, Joseph W. |
|
2017 |
36 |
4 |
p. 427-433 7 p. |
artikel |
20 |
Vascular endothelial growth factor A is associated with the subsequent development of moderate or severe cardiac allograft vasculopathy in pediatric heart transplant recipients
|
Daly, Kevin P. |
|
2017 |
36 |
4 |
p. 434-442 9 p. |
artikel |
21 |
von Willebrand factor proteolysis by ADAMTS-13 in patients on left ventricular assist device support
|
Nascimbene, Angelo |
|
2017 |
36 |
4 |
p. 477-479 3 p. |
artikel |